4,6,20,44 Combination of DPP-4 Inhibitors and GLP-1 Agonists: Because both DPP-4 inhibitors and GLP-1 agonists increase incretin, there has been interest in learning whether this combination could result in a synergistic A1C-lowering effect
This represents a fundamental difference between simply consuming water and achieving true cellular hydration
Both the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines and the American Diabetes Association (ADA) endorse multidisciplinary care coordination as a central pillar of comprehensive DKD management (167)
While the FDA has not established a specific Recommended Daily Allowance (RDA) for phosphatidylcholine, they have established an Adequate Intake (AI) for its active component, choline, which is 550 mg/day for men and 425 mg/day for women
The potential antidepressant effect of antidiabetic agents: new insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase
